Search results
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
Zacks via Yahoo Finance· 1 day agoGilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you...
Brown Advisory Inc. Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 1 day agoBrown Advisory Inc. lessened its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) ...
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association...
Morningstar· 4 hours agoGilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the ...
Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And...
Benzinga via Yahoo Finance· 2 days agoSaturday, Gilead Sciences Inc (NASDAQ:GILD), following the recent acquisition of CymaBay...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks via Yahoo Finance· 2 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in...
Investing in Gilead Sciences, Inc.
Knox Daily· 1 day agoAs a result of the transaction, Parsey Merdad now holds 92,706 shares, worth roughly $6.29 million. Maxim Group reiterated its Gilead Sciences,
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and...
Morningstar· 4 days agoInvestigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis - 70% of Patients Receiving Seladelpar 10mg Achieved the Clinically Meaningful Composite Endpoint and 37
Bernard Horn's Polaris Global Value Fund 1st-Quarter Letter: Loo
Guru Focus· 5 days agoGlobal equity markets enjoyed consecutive months of gains, with the MSCI World Index returning 8.88%...
